pamidronate has been researched along with Synovioma in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Tumor-induced hypercalcemia is a frequent complication of advanced cancers, but it has been rarely reported in patients with sarcoma." | 1.34 | Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma. ( Badiei, Z; Hiradfar, M; Vakili, R; Zabolinejad, N, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Osanai, T | 1 |
Tsuchiya, T | 1 |
Sugawara, M | 1 |
Vakili, R | 1 |
Hiradfar, M | 1 |
Zabolinejad, N | 1 |
Badiei, Z | 1 |
2 other studies available for pamidronate and Synovioma
Article | Year |
---|---|
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neopla | 2009 |
Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma.
Topics: Adolescent; Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Male; Mediastin | 2007 |